Digital biomarkers may lead to more robust clinical trials for rare diseases
- DHV-NET
- Sep 4, 2023
- 1 min read
However, work is still needed to validate their use for rare diseases
top of page
Search
Recent Posts
See AllMedical Device Development Tools (MDDT) | FDA https://www.fda.gov/medical-devices/medical-device-development-tools-mddt?utm_source=FDALin...
Walk, talk, think, see and feel: harnessing the power of digital biomarkers in healthcare | npj Digital Medicine (nature.com)...
bottom of page